Related Experiment Videos

Pharmacotherapy of pediatric lung disease: differences between children and adults

H W Kelly1

  • 1College of Pharmacy, University of New Mexico, Albuquerque.

Clinics in Chest Medicine
|December 1, 1987
PubMed

Insights

Pediatric drug dosages differ from adults due to physiological development, often requiring higher weight-based doses. Accurate drug administration in children necessitates specialized equipment like syringe infusion pumps for effective therapeutic monitoring.

Area of Science:

  • Pediatric pharmacology
  • Pharmacokinetics in children
  • Drug administration in pediatrics

Background:

  • Pediatric drug dosages significantly differ from adult dosages due to developmental physiological variations affecting drug absorption, distribution, and clearance.
  • Infants and children generally require higher therapeutic agent dosages on a weight basis compared to adults.
  • Parenteral drug administration in pediatric patients is complicated by slow fluid infusion rates.

Purpose of the Study:

  • To highlight the complexities of drug administration in pediatric populations.
  • To emphasize the importance of accurate drug monitoring and dosage adjustments in children.
  • To discuss challenges in aerosol drug delivery and the impact of pulmonary diseases on drug disposition in pediatrics.

Main Methods:

  • Review of physiological differences impacting drug pharmacokinetics in pediatric patients.
  • Analysis of challenges in parenteral and aerosol drug administration techniques for infants and children.
  • Examination of the influence of chronic and acute pulmonary diseases on drug disposition in pediatric populations.

Main Results:

  • Pediatric patients often require higher weight-based drug dosages.
  • Syringe infusion pump devices are critical for accurate drug monitoring and dosage adjustments in pediatrics.
  • Aerosol administration in pediatrics presents significant challenges, including coordination with inhalation and drug loss in endotracheal tubes.
  • Pulmonary diseases like cystic fibrosis can alter drug disposition and metabolism, requiring further study in children.

Conclusions:

  • Drug dosages and administration methods must be carefully considered in pediatric patients due to unique physiological factors.
  • Specialized equipment and techniques are essential for safe and effective drug therapy in infants and children.
  • Further research is needed to fully understand the impact of disease states on pediatric pharmacokinetics and optimize drug treatments.

Related Concept Videos